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ABSTRACT 
This study investigated the quantitative structure-activity relationship (QSAR) of imidazole 
derivatives of 4,7-disubstituted coumarins as inhibitors of aromatase, a potential therapeutic 
protein target for the treatment of breast cancer. Herein, a series of 3,7- and 4,7-disubstituted 
coumarin derivatives (1-34) with R1 and R2 substituents bearing aromatase inhibitory activity 
were modeled as a function of molecular and quantum chemical descriptors derived from 
low-energy conformer geometrically optimized at B3LYP/6-31G(d) level of theory. Insights 
on origins of aromatase inhibitory activity was afforded by the computed set of 7 descriptors 
comprising of F10[N-O], Inflammat-50, Psychotic-80, H-047, BELe1, B10[C-O] and 
MAXDP. Such significant descriptors were used for QSAR model construction and results 
indicated that model 4 afforded the best statistical performance. Good predictive performance 
were achieved as verified from the internal (comprising the training and the leave-one-out 
cross-validation (LOO-CV) sets) and external sets affording the following statistical parame-
ters: R2Tr = 0.9576 and RMSETr = 0.0958 for the training set; Q2CV = 0.9239 and RMSECV = 
0.1304 for the LOO-CV set as well as Q2Ext = 0.7268 and RMSEExt = 0.2927 for the external 
set. Significant descriptors showed correlation with functional substituents, particularly, R1 in 
governing high potency as aromatase inhibitor. Molecular docking calculations suggest that 
key residues interacting with the coumarins were predominantly lipophilic or non-polar while 
a few were polar and positively-charged. Findings illuminated herein serve as the impetus that 
can be used to rationally guide the design of new aromatase inhibitors. 
 
Keywords: Coumarin, aromatase, aromatase inhibitor, QSAR, data mining, molecular 
docking 
 
 
INTRODUCTION 
Breast cancer is commonly found in 
women and is reported as the second leading 
cause of women death (Desantis et al., 
2011). Estrogen is associated with the devel-
opment of breast cancer by activating intra-
cellular signaling cascades (Yager and Da-
vidson, 2006). Aromatase is an enzyme in-
volved in the catalysis of androgens (i.e. an-
drostenedione) to estrogens (i.e. estradiol). 
Therefore, the ability to inhibit such enzyme 
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offers great therapeutic benefits for the 
treatment of breast cancer (Narashimamurthy 
et al., 2004). Aromatase (i.e. 19A1) is a 
member of the cytochrome P450 family and 
is comprised of 503 amino acids. The proxi-
mal ligand of aromatase (i.e. Cys437) is co-
ordinated to the heme prosthetic group and it 
was previously reported that the presence of 
the characteristic cysteine proximal ligand is 
crucial for the catalytic activity observed in 
cytochrome P450s (Auclair et al., 2001; Yo-
shioka et al., 2001). Aromatase inhibitors 
comprising of steroidal and non-steroidal 
compounds have either been synthesized by 
introducing or modifying functional groups 
on the core structure of prototype lead com-
pounds (Ferlin et al., 2013; Nativelle-
Serpentini et al., 2004; Neves et al., 2009; 
Stefanachi et al., 2011; Varela et al., 2012) 
or extracted from natural sources (Balunas et 
al., 2008). In addition, computational analy-
sis such as quantitative structure-activity re-
lationship (QSAR), molecular docking and 
modeling had previously been employed for 
constructing models and interpreting the in-
teraction between compounds of interest 
with the aromatase enzyme (Bheemanapalli 
et al., 2013; Galeazzi and Massaccesi 2012; 
Ghosh et al., 2012; Nantasenamat et al., 
2013a, b; Narayana et al., 2012).  
Coumarin is a naturally occurring bioac-
tive benzopyrone found in many plant spe-
cies (Venugopala et al., 2013). It represents 
an important structural scaffold in medicinal 
chemistry as it can afford a wide range of bi-
oactivities such as anti-bacterial (Nagamallu 
and Kariyappa, 2013), anti-cancer (Wu et al., 
2014), anti-inflammatory (Hemshekhar et 
al., 2013), anti-oxidant (Guinez et al., 2013) 
as well as neuroprotective (Sun et al., 2013) 
properties. Furthermore, 7-hydroxycoumarin 
is the primary metabolite of coumarin in 
human. A number of 7-oxy substituted cou-
marin analogs have been shown to exhibit an 
array of bioactivities (Venugopala et al., 
2013). Recently, 3,7- and 4,7-disubstituted 
coumarin derivatives (1-34, Figure 1) have 
been reported to display aromatase inhibitory 
potency in the nanomolar range (Stefanachi 
et al., 2011). 
The aim of this study is to explain the or-
igins of aromatase inhibitory activity via 
QSAR modeling and molecular docking. 
QSAR models were built as a function of 
significant descriptors accounting for aroma-
tase inhibitory activity. Insights into struc-
ture-activity relationship are also discussed 
and it is anticipated that such information 
could serve as a pertinent guideline for the 
rational design of novel aromatase inhibitors 
based on the coumarin chemotype. 
 
MATERIALS AND METHODS 
Data set 
A set of coumarin derivatives with re-
ported aromatase inhibitory activity was tak-
en from the work of Stefanachi et al. (2011). 
Briefly, the aromatase inhibitory activity was 
determined in vitro using human placental 
microsomes as the source of aromatase while 
[1β-3H] androstenedione was used as the 
substrate. IC50 values were logarithmically 
transformed to pIC50 as summarized by the 
following equation: 
pIC50 = -log10(IC50)  [1] 
Chemical structures are depicted in Fig-
ure 1 while its corresponding descriptors and 
bioactivity are shown in Table 1. Schematic 
workflow of this study is displayed in Figure 
2. 
 
Geometrical optimization and descriptors 
calculation 
Molecular structures were drawn using 
ChemAxon MarvinSketch version 6.2.1 
(ChemAxon Ltd., 2014) and converted to the 
appropriate file format with Babel version 
3.3.0 (OpenEye Scientific Software, 2014). 
An initial geometrical optimization was per-
formed at the semi-empirical Austin Model 1 
(AM1) level followed by further refinement 
at the density functional theory (DFT) level 
using the Becke’s three parameter hybrid 
method and the Lee-Yang-Parr (B3LYP) 
functional together with the 6-31g(d) basis 
set using the Gaussian 09 software package  
 
EXCLI Journal 2014;13:1259-1274 – ISSN 1611-2156 
Received: July 08, 2014, accepted: November 18, 2014, published: December 08, 2014 
 
 
1261 
(Frisch et al., 2009). A set of 6 quantum 
chemical descriptors were obtained from the 
aforementioned low-energy conformer that 
included the following: dipole moment (µ), 
the total energy, the highest occupied molec-
ular orbital energy (HOMO), the lowest un-
occupied molecular orbital (LUMO), differ-
ence in energy values of HOMO and LUMO 
(HOMO-LUMO) and the mean absolute 
atomic charge (Qm) (Karelson et al., 1996; 
Thanikaivelan et al., 2000). Furthermore, the 
low-energy conformer were also subjected to 
the generation of additional descriptors from 
the Dragon software package, version 5.5 
(Talete, 2007) to derive a set of 3,224 mo-
lecular descriptors comprising 22 categories: 
48 Constitutional descriptors, 119 Topologi-
cal descriptors, 47 Walk and path counts, 33 
Connectivity indices, 47 Information indices, 
96 2D autocorrelation, 107 Edge adjacency 
indices, 64 Burden eigenvalues, 21 Topolog-
ical charge indices, 44 Eigenvalue-based in-
dices, 41 Randic molecular profiles, 74 Ge-
ometrical descriptors, 150 RDF descriptors, 
160 3D-MoRSE descriptors, 99 WHIM de-
scriptors, 197 GETAWAY descriptors, 154 
Functional group counts, 120 Atom-centered 
fragments, 14 Charge descriptors, 29 Molec-
ular properties, 780 2D binary fingerprints 
and 780 2D frequency fingerprints.  
 
Descriptors selection 
Constant variables from the initial set of 
3,224 molecular descriptors obtained from 
the Dragon software were subjected to re-
moval and subsequently combined with a set 
of 6 quantum chemical descriptors. Signifi-
cant descriptors correlated with the aroma-
tase inhibitory activity were derived from 
stepwise multiple linear regression 
(Worachartcheewan et al., 2014) using SPSS 
Statistics version 18.0 (SPSS Inc., USA). In-
tercorrelation matrix of descriptors was con-
structed from Pearson’s correlation coeffi-
cient values as to deduce the presence of var-
iable redundancy. 
 
Generation of internal and external sets 
The data set was divided into 2 major 
subsets in which an external set was obtained 
by randomly selecting 15 % of the data sam-
ples from the full data set while the remain-
ing 85 % served as the internal set 
(Nantasenamat et al., 2013a). The internal set 
was used to internally assess the predictive 
performance of QSAR models by using 
 
 
Figure 1: Chemical structures of disubstituted coumarins 1-34 
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Table 1: Molecular descriptors and aromatase inhibitory activity of coumarins (1-34) 
Cpd. 
Descriptors  Activity 
F10[N-O] Inflammat-50 
Psychotic-
80 H-047 BELe1 B10 [C-O] MAXDP  
IC50 
(µM) pIC50 
1 0 0 1 13 1.920 1 4.891  0.150 6.824 
2 0 0 1 12 1.922 1 4.929  0.114 6.943 
3 0 0 1 12 1.920 1 5.234  0.113 6.947 
4 0 0 1 12 1.920 1 4.914  0.130 6.886 
5 0 0 1 12 1.921 1 4.916  0.235 6.629 
6 0 0 0 12 1.920 1 4.937  0.207 6.684 
7 0 0 1 12 1.922 1 4.929  0.141 6.851 
8 0 0 1 12 1.920 1 4.947  0.267 6.573 
9 0 0 1 12 1.920 1 4.910  0.178 6.750 
10 0 0 1 15 1.920 1 4.940  0.127 6.896 
11 0 0 0 12 1.920 1 4.930  0.481 6.318 
12 0 1 0 11 1.923 1 4.870  0.169 6.772 
13 0 0 1 11 1.920 1 5.271  0.165 6.783 
14 0 1 0 11 1.923 1 4.870  0.051 7.292 
15 0 1 0 10 1.923 1 5.262  0.072 7.143 
16 0 1 0 10 1.923 1 4.897  0.072 7.143 
17 0 0 1 13 1.924 1 4.937  0.292 6.535 
18 0 0 1 10 1.926 1 4.907  0.690 6.161 
19 0 1 0 10 1.923 1 4.893  0.112 6.951 
20 1 1 0 10 1.925 1 4.910  0.164 6.785 
21 0 0 1 10 1.926 1 4.939  0.296 6.529 
22 0 0 1 16 1.925 1 4.967  0.081 7.092 
23 0 1 0 9 1.923 1 5.283  0.070 7.155 
24 0 1 0 9 1.923 1 5.299  0.047 7.328 
25 0 1 0 11 1.935 1 4.890  0.105 6.979 
26 0 0 0 6 1.914 0 4.471  3.750 5.426 
27 0 0 0 9 1.916 0 4.600  0.280 6.553 
28 0 0 1 13 1.955 1 5.177  0.455 6.342 
29 0 0 1 15 1.958 1 5.447  0.067 7.174 
30 0 0 1 13 1.957 1 5.503  0.317 6.499 
31 0 0 0 14 1.957 1 5.480  0.532 6.274 
32 2 0 1 14 1.962 1 5.504  4.010 5.397 
33 1 0 0 9 1.908 1 4.918  2.820 5.550 
34 1 0 1 15 1.945 1 5.972  0.313 6.504 
 
 
it as training and leave-one-out cross-
validated (LOO-CV) sets. LOO-CV refers to 
the leaving out of one data sample as the 
testing set while using the remaining N-1 
samples as the training set. The process was 
iteratively repeated until all samples were 
used as the testing set. As the name implies, 
the external set was used to externally assess 
the predictive performance of the QSAR 
model. 
 
Multiple linear regression  
Multiple linear regression (MLR) ws 
employed for constructing QSAR models as 
conceptually summarized by the following 
equation: 
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 [2] 
where Y is the aromatase inhibitory activity 
(pIC50), m is the regression coefficient value 
of descriptors, x is the descriptor and b 
repreents the y-intercept value. MLR calcula-
tions were used as implemented by the Wai-
kato Environment for Knowledge Analysis 
(WEKA) software, version 3.4.5 (Witten et 
al., 2011). 
 
 
Figure 2: Schematic workflow of QSAR and mo-
lecular docking studies performed herein 
 
 
Statistical analysis 
Evaluation of the predictive performance 
of QSAR models was performed using 
squared correlation coefficient for the trai-
ning (R2Tr) and cross-validated sets (Q2CV) as 
well as the root mean squared error for the 
training (RMSETr) and cross-validated sets 
(RMSECV). Furthermore, the Fisher (F) ratio 
as well as the difference of R2 and Q2 
(R2−Q2) was used to assess the predictive 
quality of constructed models. Moreover, 
squared correlation coefficient (Q2Ext) and 
root mean squared error (RMSEExt) of ex-
ternal set were used as independent validati-
on of the constructed QSAR model (Nanta-
senamat et al., 2013a). 
 
Molecular docking 
The set of 34 coumarin compounds was 
used as ligands for docking to the X-ray 
crystallographic structure of aromatase (PDB 
id 3EQM). Prior to docking, both protein and 
ligand structures were subjected to a series 
of pre-processing. A snapshot of the aroma-
tase structure was obtained from 100 ns of 
molecular dynamics simulation using the 
AMBER03 force field under YASARA 
10.11.28 (Krieger et al., 2002, 2003) as re-
ported in our previous investigation (Suvan-
nang et al., 2011). Subsequently, atomic 
charges of the heme prosthetic group were 
parameterized according to density function-
al calculations reported by Favia et al. 
(2006). Low-energy conformer of ligands as 
obtained from previously mentioned geomet-
rical optimization. Kollman and Gasteiger 
charges were finally assigned to the protein 
and ligands, respectively, using AutoDock-
Tools (Morris et al., 2009). 
Docking calculatons were performed us-
ing AutoDock version 4.2 (Morris et al., 
2009). A grid box was constructed using Au-
toGrid and centered at the binding cavity us-
ing x,y,z coordinates of 84.0236, 49.6568, 
50.0293 where it is encapsulated by a box 
size of 52 × 66 × 82 Å points with spacing of 
0.3759 Å. Each docking pose was obtained 
from 100 independent runs based on 150 
randomly placed individuals in the popula-
tion. The docking simulation made use of the 
Lamarckian Genetic Algorithm (Morris et 
al., 1998) in searching for low-energy bind-
ing orientation. Translation step of 2.0 Å, 
mutation rate of 0.02, crossover rate of 0.8, 
local search rate of 0.06 and maximum ener-
gy evaluation of 250,000,000 were utilized 
in the present docking simulation. Docked 
conformations were clustered using an 
RMSD tolerance of 2.0 Å. Re-docking of the 
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co-crystallized substrate was performed as to 
evaluate the validity of the docking protocol. 
Post-docking analyses were carried out 
using AutoDockTools and graphical images 
were prepared using PyMOL version 0.99 
(Delano, 2002). 
 
RESULTS AND DISCUSSION 
Chemical space of investigated coumarins 
Stefanachi et al. (2011) reported the syn-
thesis and determination of aromatase inhibi-
tory activity for a set of coumarin derivatives 
(1-34) as shown in Figure 1. The coumarin 
core structure featured various substituents 
(i.e. halogen, methoxy, aryloxy and imidaz-
ole) that conferred its bioactivity against 
aromatase (Table 1). In gaining further in-
sights on the general features of potency af-
forded by these coumarins, compounds hav-
ing pIC50 values greater than 7 (< 0.081 nM) 
were considered active, less than 6 as inac-
tive (> 2.82 μM) and values in between were 
considered to have intermediate activity. It 
can be seen that the potency of this set of 
compounds was relatively robust as deduced 
from IC50 values in the range of 47 nM to 
690 nM for 31 out of the 34 compounds. The 
remaining three compounds afforded poor 
IC50 values in the range of 2.820 and 
4.010 μM. 
Applying the Lipinski’s rule-of-five on 
this set of compounds revealed its compli-
ance in which there were less than 5 H-bond 
donors, less than 10 H-bond acceptors, mo-
lecular weight (MW) of less than 500 Da and 
Ghose–Crippen octanol–water partition co-
efficient (ALogP) of less than 5 (Supplemen-
tary Information). An exploratory data anal-
ysis of the three aforementioned sub-classes 
revealed that intermediate and active sub-
classes were generally larger than their inac-
tive counterpart with MW of 361.246 ± 
39.971, 353.146 ± 23.348 and 305.997 ± 
98.512 Da, respectively. However, it should 
be noted that of the three compounds in the 
inactive sub-class, 32 had significantly high-
er MW of 419.46 Da than the remaining two 
with MW of 242.25 and 256.28 Da for 26 
and 33, respectively. The number of H-bond 
donors does not appear to be crucial for its 
bioactivity as can be seen from the sparse-
ness of their occurrence in the coumarins in 
which a total of two compounds had one H-
bond donor belonging to the inactive (26) 
and intermediate (25) sub-class. As for the 
number of H-bond acceptors, the intermedi-
ate and active sub-classes had slightly higher 
mean values of 4.958 ± 1.268 and 4.857 ± 
0.900, respectively, when compared to that 
of the inactive sub-class with corresponding 
value of 4.333 ± 0.577. Finally, analysis of 
ALogP revealed that the inactive sub-class 
afforded higher polarity with a mean of 
2.459 ± 1.848 than both the intermediate and 
active sub-classes, which gave 3.634 ± 0.922 
and 3.592 ± 0.537, respectively. A closer 
glance of the inactive sub-class shows that 
32 afforded significantly higher ALogP val-
ue of 4.588 than the other two compounds 
(26 and 33) having values of 1.269 and 1.52. 
 
Data pre-processing and feature selection 
Quantum chemical descriptors of com-
pounds from low energy conformer of com-
pounds derived from geometrical optimiza-
tion at B3LYP/6-31g(d). Furthermore, low 
energy conformer was then subjected to fur-
ther calculation using the Dragon software 
for generating an additional set of molecular 
descriptors. The usefulness of quantum 
chemical and molecular descriptors in con-
structing QSAR/QSPR models of chemical 
properties (Nantasenamat et al., 2005, 2007a, 
b) and biological activities (Khoshnevisza-
deh et al., 2012; Martinez-Martinez et al., 
2012; Nantasenamat et al., 2010, 2013b; 
Uesawa et al., 2011; Worachartcheewan et 
al., 2011, 2013) had previously been demon-
strated. Constant and multi-collinear de-
scriptors were removed from the initially 
large set of 3,224 descriptors from Dragon 
resulting in a reduced subset of 1,129 molec-
ular descriptors. Subsequently, this set of de-
scriptors was then combined with a set of 6 
quantum chemical descriptors to give rise to 
a total of 1,135 descriptors. Such combined 
set was then subjected to stepwise MLR for 
further round of feature selection thereby re-
EXCLI Journal 2014;13:1259-1274 – ISSN 1611-2156 
Received: July 08, 2014, accepted: November 18, 2014, published: December 08, 2014 
 
 
1265 
sulting in 7 significant descriptors consisting 
of F10[N-O], Inflammat-50, Psychotic-80, 
H-047, BELe1, B10[C-O] and MAXDP. Ta-
bles 1 and 2 display the molecular de-
scriptors constituting the data set and the 
definition of significant descriptors, respec-
tively. An intercorrelation matrix of Pear-
son’s correlation coefficient was constructed 
as to verify the independence of the constitu-
ent variables in this set of molecular de-
scriptors. Results indicated that this set of 7 
descriptors were independent from one an-
other as deduced by the low correlation coef-
ficient values (Table 3). 
 
QSAR model of aromatase inhibitory  
activity 
The set of 7 significant descriptors were 
then used in the development of QSAR 
models using MLR to deduce a linear equa-
tion as described by Eq. (2). Thus, such mul-
tivariate analysis generated a total of 4 mod-
els consisting of MLR equations and statisti-
cal analysis as summarized in Table 4. In-
herent outliers present in each of the MLR 
models were identified using absolute stand-
ardized residual of 2 as the cutoff. 
The initial model 1 produced the follow-
ing MLR equation and statistical parameters: 
 
Table 2: Definition of important descriptors for QSAR model 
Symbol Definition Type 
F10[N-O] Frequency of N-O at topological distance 10 2D frequency fingerprints 
Inflammat-50 Ghose-Viswanadhan-Wendoloski anti-inflammatory-
like index at 50 % 
Molecular properties 
Psychotic-80 Ghose-Viswanadhan-Wendoloski anti-psychotic-like 
index at 50 % 
Molecular properties 
H-047 H attached to C1(sp3)/C0(sp2) Atom-centred fragments 
BELe1 Lowest eigenvalue n.1 of Burden matrix/weighted by 
atomic Sanderson electronegativities 
Burden eigenvalues 
B10[C-O] Presence/absence of C-O at topological distance 10 2D binary fingerprints 
MAXDP Maximal electrotopological positive variation Topological descriptors 
 
 
 
Table 3: Intercorrelation matrix of significant descriptors for QSAR model 
 F10[N-O] Inflammat-50 
Psychotic-
80 H-047 BELe1 B10[C-O] MAXDP 
F10[N-O] 1.0000       
Inflammat-
50 -0.0636 1.0000      
Psychotic-
80 0.0105 -0.7346 1.0000     
H-047 0.1205 -0.5443 0.6005 1.0000    
BELe1 0.2980 -0.1769 0.2311 0.5513 1.0000   
B10[C-O] 0.0708 0.1166 0.2249 0.2614 0.1685 1.0000  
MAXDP 0.3587 -0.1136 0.2099 0.4372 0.6917 0.3267 1.0000 
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pIC50 = - 0.5797(F10[N-O]) +     [3] 
1.0993(Inflammat-50) +  
0.4107(Psychotic-80) +  
0.1123(H-047) - 13.2991(BELe1) -  
0.6687 (B10[C-O]) + 
0.4336(MAXDP) + 29.0288 
N = 29, R2Tr = 0.9036, RMSETr = 0.1412, 
Q2CV = 0.7693, RMSECV = 0.2238, F ratio = 
10.00, critical F value = 2.488 and R2Tr - 
Q2CV = 0.1343 
The model showed compounds 27 and 29 
as outliers, which were removed from the 
model and the resulting data set was re-
calculated to generate Model 2 as shown be-
low. 
pIC50 = - 0.5407(F10[N-O]) + [4] 
1.0870(Inflammat-50) + 
0.4025(Psychotic-80) +  
0.1051(H-047) - 15.5871(BELe1) +  
0.4285(MAXDP) + 32.8689  
N = 27, R2Tr = 0.9347, RMSETr = 0.1179, 
Q2CV = 0.8821, RMSECV = 0.1585, F ratio = 
24.94, critical F value = 2.599 and R2Tr - 
Q2CV = 0.0526 
It was observed that B10[C-O] was re-
moved from the MLR equation owing to the 
fact that the remaining 27 compounds had 
constant value of 1 for the B10[C-O] de-
scriptor. Likewise, compound 20 was detect-
ed as the outlying compound and following 
its removal yielded model 3 as described be-
low. 
pIC50= - 0.6008(F10[N-O]) + [5] 
1.0371( Inflammat-50) + 
0.3941(Psychotic-80) 
+ 0.1042(H-047) - 15.7039(BELe1)  
+ 0.4959( MAXDP) + 32.7809 [5] 
N = 26, R2Tr = 0.9496, RMSETr = 0.1082, 
Q2CV = 0.9111, RMSECV = 0.1423, F ratio = 
32.44, critical F value = 2.628 and R2Tr - 
Q2CV = 0.0385 
Subsequently, compound 18 was identi-
fied as the outlying compound and its re-
moval resulted in model 4: 
pIC50 = - 0.6067(F10[N-O]) +  [6] 
1.0108(Inflammat-50) + 
0.4262(Psychotic-80) +  
0.0884(H-047) - 14.5495(BELe1) + 
0.4563(MAXDP) + 30.9432  
N = 25, R2Tr = 0.9579, RMSETr = 0.0958, 
Q2CV = 0.9239, RMSECV = 0.1304, F ratio = 
36.42, critical F value = 2.661 and R2Tr - 
Q2CV = 0.0340 
This final model 4 was shown to afford 
robust predictive performance as verified 
from its statistical parameters for both the 
training and LOO-CV sets. Scatter plots of 
experimental versus predicted pIC50 values 
for the 4 models of the training and LOO-CV 
sets are presented in Figures 3a-d as white 
and black squares, respectively. Interesting-
ly, the statistical performance increased from 
Eq. 3 to Eq. 6 as deduced from the increas-
ing Q2 and F ratio. A metric proposed by 
Eriksson and Johansson (1996) for evaluat-
ing the reliability of predictive models was 
obtained by calculating the difference of R2 
and Q2. A value in excess of 0.3 is indicative 
of chance correlation or the presence of out-
liers. Thus, the R2−Q2 from the training and 
LOO-CV sets were found to be < 0.3 thereby 
indicating its statistical significance. The ex-
perimental and predicted pIC50 values along 
with their respective residuals are provided 
in Table 5. 
 
Validation of QSAR model using external 
set 
The predictivity of QSAR models 1-4 
was verified by external validation using 
15 % of samples from the original data set 
(i.e. comprising of compounds 4, 6, 12, 17 
and 26). It should be noted that the external 
set was randomly selected and their distribu-
tion are shown in Figure 4 as black squares 
along with the internal set shown as white 
squares. The internal and external predictivi-
ty of models 1-4 were determined and results 
suggested good predictive performance es-
pecially by model 4, which provided Q2CV = 
0.9239, RMSECV = 0.1304 and Q2Ext = 
0.7268. Model 4 was selected for further in-
vestigation owing to its absence of outlying 
compounds and its ability to perform well on 
both the internal and external sets. Moreover, 
R2−Q2 calculated from training and external 
sets afforded a value of < 0.3, which sug-
gests the model’s reliability.  
EXCLI Journal 2014;13:1259-1274 – ISSN 1611-2156 
Received: July 08, 2014, accepted: November 18, 2014, published: December 08, 2014 
 
 
1267 
Table 4: Summary of predictive performance of QSAR model 
Modela 
Training set  LOO-CV set  External set 
N R2Tr RMSETr  N Q2CV RMSELOO-CV  N Q2Ext RMSEExt 
1 29 0.9036 0.1412  29 0.7693 0.2238  5 0.4017 0.4514 
2 27 0.9347 0.1179  27 0.8821 0.1585  5 0.7291 0.2986 
3 26 0.9496 0.1082  26 0.9111 0.1423  5 0.7517 0.2815 
4 25 0.9579 0.0958  25 0.9239 0.1304  5 0.7268 0.2927 
a Compounds 18, 20, 27 and 29 as outliers were removed from the models.  
 
 
Figure 3: Plot of experimental versus predicted aromatase inhibitory (pIC50) activity for the training set 
(white squares; regression line is represented as solid line), leave-one-out cross-validation set (black 
squares; regression line is represented as dotted line) and external test set (blue triangles) for model 1 
(a), model 2 (b), model 3 (c) and model 4 (d) 
 
 
Plots of experimental and predicted pIC50 
values for the 4 models of the external set are 
presented in Figures 3a-d as blue triangles. 
As previously mentioned for the internal set, 
the corresponding values of the experimental 
and predicted pIC50 values and their respec-
tive residuals are shown in Table 5. 
Elucidating structure-activity relationship 
Aromatase inhibitory potency (IC50 val-
ue) of coumarin analogs was transformed to 
pIC50 using Eq. (1) and was used as the de-
pendent variable. Feature selection per-
formed on a set of molecular and quantum 
chemical descriptors yielded 7 significant 
descriptors as follows (listed in order of rela-
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tive importance as deduced from the MLR 
regression coefficient values): BELe1 (Bur-
den eigenvalues) > Inflammat-50 (molecular 
properties) > B10[C-O] (2D binary finger-
prints) > F10[N-O] (2D frequency finger-
prints) > MAXDP (Topological descriptors) 
> Psychotic-80 (molecular properties) > H-
047 (Atom-centered fragments). 
Disubstituted coumarin pharmacophores 
bearing 7-ether linkage and 4-methyli-
midazole moieties displayed different poten-
cy in their aromatase inhibitory effect. The 
QSAR study revealed many significant de-
scriptors plausibly governing its interaction 
with aromatase. Such descriptors provided 
information on the types of functional groups 
related to their lipophilicity, polarity and 
isomeric effects as well as appropriate dis-
tance of functional groups. 
In the series of 7-benzyloxy courmarin 
(1-13, R1 = CH2C6H5, R2 = H), BELe1 val-
ues weighted by atomic Sanderson electro-
negativities were shown to be in the range of 
1.920-1.923 where the phenyl groups (R1) 
were substituted with m– and p-Me, F, Cl, 
OMe, OCF3 and NO2. Interestingly, m-
substituents such as F (3), Cl (4), OCF3 (6) 
exhibited higher aromatase inhibitory activi-
ty than their corresponding p-substituent (8, 
9, 11) counterparts. The m-F compound 3 
was shown to be the strongest aromatase in-
hibitor but compound 11 bearing the p-OCF3 
moiety displayed the least activity. A closer 
look revealed that the compounds had the 
same value of BELel of 1.920 while afford-
ing different value for the maximal elec-
trotopological positive variation (MAXDP) 
with corresponding values of 5.234, 4.937 
and 4.914 for m-F (3), m-OCF3 (6) and m-Cl 
(4), respectively. In comparison with the cor-
responding p-substituted phenyl compounds 
(8, 9, 11), their MAXDP values (4.947, 
4.930, 4.910, respectively) were relatively 
less than those of the m-substituted com-
pounds (3, 4, 6). It can thus be presumed that 
an unsymmetrical m-substituted phenyl (R1) 
compounds (3, 4, 6) displayed higher 
MAXDP values as compared to a symmet-
rical p-substituted compounds (8, 9, 11). 
Similarly, the unsymmetrical 3,4-di F phe-
nyl compound (13) had higher MAXDP val-
ue (5.271) than the symmetrical 3,5-di F 
analog (12) with MAXDP value of 4.870. 
It was noted that for a series of 7-
phenoxy coumarins (14-24, R1 = C6H5, R2 = 
H), the unsymmetrical 3,4-di F phenyl (24) 
had higher MAXDP value as compared to 
the symmetrical 3,5-di F analog (23). As for 
the series of R1 (CH3 and C6H5) containing 
chiral center at the C-4 position of the cou-
marin ring (28-32), the 3,4-di F phenyl ana-
log 30 bearing phenyl group at the C-4 me-
thine carbon atom had higher MAXDP value 
(5.503) when compared to the most potent 
aromatase inhibitor 24 (without chiral cen-
ter) having MAXDP = 5.299. So far, the 
3,4-di F phenyl analog 24 displayed 6.74 
folds higher aromatase inhibitory activity 
than analog 30. In addition, analog 24 exhib-
ited higher activity (1.43 folds) than analog 
29 containing phenyl moiety (R2) at the C-4 
methine carbon but without 3,4-di F substi-
tuted at the phenyl ring (R1). The results in-
dicated that 3,4-di F phenyl group (R1) pre-
dominantly governed the aromatase inhibito-
ry activity as compared to the phenyl ring 
(R2). This could be attributed to the fact that 
compounds 29 and 30, which contain steric 
effect from phenyl group at the C-4 methine 
carbon, could prevent its binding or interac-
tion with the target site of action. The 7-
phenoxy compound 24 (without phenyl 
group at the methine carbon) was reported to 
bind the aromatase active site (heme iron) 
via coordination with the lone pair electron 
from N atom of the imidazole ring in such a 
way that the imidazole ring at the C-4 posi-
tion is perpendicular to the coumarin ring 
(Stefanachi et al., 2011). 
Coumarin analogs (R1 = C6H5) without 
the 3,4-di F group such as 31 (R2 = C6H4-
Cl-p) and 32 (R2 = C6H4-CN-p) afforded 
high MAXDP (5.480 and 5.504) and high 
BELe1 (1.957 and 1.962) values, respective-
ly. Notably, the inductive effect of the p-CN 
group (32) can provide the resonant ionic 
charge distribution form (32a, Figure 5) ac-
counting for its higher MAXDP and BELe1 
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values than that of the p-Cl analog 31. 
Amongst the 4,7-disubstituted coumarins (1-
32), analog 32 was shown to be the least po-
tent aromatase inhibitor in which such re-
markably low activity of 32 might be due to 
the ionic charge 32a and the bulky p-CN 
phenyl group (at chiral center). 
On the other hand, 7-hydroxy 26 (R1 = 
H) and methoxy 27 (R1 = CH3) coumarins 
showed low values of MAXDP (4.471 and 
4.6000) and BELe1 (1.914 and 1.916). Such 
low values for these descriptors could be 
possibly a result from the lack of phenoxy 
group at the C-7 position (26 and 27) in con-
tributing lone pair electron from the O atom 
into the phenyl ring (R1) leading to higher 
topological positive variation as compared to 
that of the 7-phenoxy compound 14 that can 
provide positively-charged molecule 14a 
(Figure 5).  
Similarly, the electronic effect of the 7-
phenylamino group (25) on the coumarin 
core structure could plausibly give rise to 
positively-charged species 25a (Figure 5) 
with high MAXDP value of 4.890. It should 
be noted that all compounds (1-34) share the 
common ionic charge distribution form (1A) 
as shown in Figure 5. 
However, the highest MAXDP value 
(5.972) was noted for the 3-substituted imid-
azolylcoumarin 34 as compared to the 4-sub- 
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Figure 4: Plot of molecular weight versus aroma-
tase inhibitory activity (pIC50) used in selection 
of external (black squares) and internal (white 
squares) sets 
Table 5: Experimental and predicted aromatase 
inhibitory activities (pIC50) of coumarin analogs 
(1-34) obtained from model 4 
Compound Experimental pIC50 
Predicted 
pIC50 
Residual
1 6.824 6.814 -0.010 
2 6.943 6.691 -0.252 
3 6.947 6.872 -0.075 
4a 6.886 6.737 -0.149 
5 6.629 6.734 0.105 
6a 6.684 6.322 -0.362 
7 6.851 6.701 -0.150 
8 6.573 6.771 0.198 
9 6.750 6.734 -0.016 
10 6.896 7.059 0.163 
11 6.318 6.319 0.001 
12a 6.772 7.170 0.398 
13 6.783 6.82 0.037 
14 7.292 7.139 -0.153 
15 7.143 7.084 -0.059 
16 7.143 7.289 0.146 
17a 6.535 6.778 0.243 
18 6.161 ND - 
19 6.951 7.120 0.169 
20 6.785 ND - 
21 6.529 6.469 -0.060 
22 7.092 7.012 -0.080 
23 7.155 7.189 0.034 
24 7.328 7.146 -0.182 
25 6.979 7.013 0.034 
26a 5.426 5.666 0.240 
27 6.553 ND - 
28 6.342 6.481 0.139 
29 7.174 ND - 
30 6.499 6.583 0.084 
31 6.274 6.095 -0.179 
32 5.397 5.207 -0.190 
33 5.550 5.744 0.194 
34 6.504 6.530 0.026 
ND = not determined owing to the fact that the compounds 
were outliers. 
aCompounds were used as external set. 
 
stituted imidazolylcoumarin analog 29 
(MAXDP = 5.447). This could probably be 
due to the distance or position of substituents 
on the coumarin ring that affected its reso-
nant ionic charge formation. The 3-imidazole  
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Figure 5: Chemical structures of ionically charged resonant forms 
 
 
substituent of coumarin 34 lying in close 
proximity to the carbonyl lactone that induc-
es higher charge distribution (34a) as de-
duced from the high MAXDP value as com-
pared to the corresponding value of 4-
substituted coumarin 29 showing ionic 
charge formation (29a) as illustrated in Fig-
ure 5. Apparently, the ionic form 34a pro-
vided the oxy anion that could attack the 
imine moiety of the imidazole ring to form 
negatively-charged N atom on the imidazole 
moiety (34b, Figure 5). This may be ac-
counted for by the higher MAXDP value of 
34 than that of compound 29.Taken together, 
the lipophilic property of R1 substituents 
play crucial role in affording appropriately 
high values of MAXDP and BELe1 that ac-
counted for the potent aromatase inhibitory 
effect. Particularly, the phenoxy analog 24 
bearing 3,4-di F phenyl (R1) exerted the 
most potent activity as compared to the cor-
responding 3,4-di F benzyl (R1) analog 13. 
This can be attributed to the correlation of 
descriptors as well as electronic effect of 
functional groups in contributing ionic 
charge resonant forms as well as the proper 
distance between R1 and the coumarin core 
structure in which the phenoxy (R1 = phenyl) 
coumarin analog gave the best fit in interact-
ing with the target site. 
 
Molecular docking of coumarins to  
aromatase 
Insights on the binding modality of cou-
marins to aromatase were elucidated by 
means of molecular docking. Particularly, 
low-energy conformers of coumarins ob-
tained from aforementioned quantum chemi-
cal calculations were docked to the previous-
ly reported protein structure of aromatase 
(Suvannang et al., 2011) that had been sub-
jected to 100 ns of molecular dynamics sim-
ulation. The azole moiety is central to the in-
teraction of non-steroidal AIs with the iron 
atom of the metalloporphyrrins (Balding et 
al., 2008; Maurelli et al., 2011; Pearson et 
al., 2006). The handling of metal ions is not 
a trivial task and poses a great challenge in 
molecular docking and heme-containing pro-
teins are particularly difficult to deal with 
owing to deficiencies in scoring function or 
the less stringency imposed by heme co-
factors when compared to those of other 
metal ions (Irwin et al., 2005; Seebeck et al., 
2008). Thus, to counter this limitation and 
ensure reliable interpretations we selected 
only docking conformations in which the az-
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ole moiety is oriented towards the heme co-
factor for further analysis. 
Binding poses with the lowest docked 
energy and belonging to the top-ranked clus-
ter was selected as the final model for post-
docking analysis with AutoDock Tools and 
PyMOL. Towards understanding the key res-
idues involved in the protein-ligand interac-
tion, we focused on residues within 4 Å 
around the docked ligands and this is depict-
ed in Figure 6 where panel a shows all lig-
ands docked to the aromatase binding pocket 
while panel b shows the most potent com-
pound 24 as a representative example. Resi-
dues found interacting with most of the in-
vestigated coumarin chemotype were primar-
ily lipophilic or non-polar residues compris-
ing of Ile305, Ala306, Val370, Leu372, 
Met374, Leu477 and Ser478. Furthermore, 
polar and positively-charged residues includ-
ed Thr310 and Arg115, respectively. Thus, it 
can be seen that aside from the azole-heme 
interaction and two polar residues, the pro-
tein-ligand interactions under investigation 
were predominantly lipophilic in nature. The 
aforementioned residues coincided with pre-
viously reported key residues in the binding 
cavity of aromatase (i.e. Ala306, Thr310, 
Met374 and Ser478) (Favia et al., 2013; Lo 
et al., 2013; Suvannang et al., 2011). Moreo-
ver, as the crystal structure suggests, the 
dominance of lipophilic residues could be 
accounted for by its role in forming an an-
drogen-specific cleft that binds snugly to the 
androstenedione (Ghosh et al., 2009). 
A closer analysis of the docking poses 
was carried out by stratifying this set of 34 
coumarin analogs to 3 sub-classes (i.e. ac-
tive, intermediate and inactive) on the basis 
of their pIC50 in which compounds having 
values greater than 7 were considered active, 
less than 6 as inactive and values in between 
were designated as intermediate. The general 
key residues found in both active and inac-
tive sub-classes consisted of Ala306, Thr310 
and Met374. Particularly, active compounds 
were found to interact with Phe221, Trp224, 
Leu228, Ile305, Asp309, Leu477 and Ser478 
however these residues were not involved in 
interacting with the inactives. 
 
 
 
Figure 6: Docking poses of all 34 coumarins (a) 
and the most potent compound 24 (b) within the 
confinement of the aromatase binding pocket 
 
CONCLUSION 
This study describes the QSAR study of 
imidazole derivatives of 3,7- and 4,7-
disubstituted coumarins having R1 and R2 
substituents as inhibitors of the aromatase 
enzyme. Significant molecular descriptors 
were identified to include F10[N-O], In-
flammat-50, Psychotic-80, H-047, BELe1, 
B10[C-O] and MAXDP, which were used in 
the construction of QSAR models using the 
MLR method. Multivariate analysis afforded 
good predictive performance for the cross-
validated internal set with Q2CV = 0.9239 and 
RMSECV = 0.1304 while an external valida-
tion confirmed its robustness with Q2Ext = 
0.7268 and RMSEExt = 0.2927. Insights on 
the structure-activity relationship of com-
pounds were also discussed in light of the se-
lected set of significant descriptors in con-
comitant with structural details from substit-
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uents R1 and R2. Both QSAR model and mo-
lecular docking investigations suggest that 
the aromatase inhibitory activity of com-
pounds was primarily dependent on lipo-
philic properties and the position of substitu-
ent (R1) on the coumarin core structure. 
Structural knowledge gained from QSAR 
models and molecular docking could be used 
to guide the rational design of novel aroma-
tase inhibitors. 
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